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IMPORTANCE INTRODUCTION 61
In 2017, an estimated US $3.1 billion was spent on malaria control worldwide. Despite 62 this expenditure, around half a million deaths due to malaria were reported that year (1). 63
Plasmodium falciparum, one of the five species that cause human malaria, accounts for the vast 64 majority of these deaths (1). While still unacceptably large, the latest mortality figure represents 65 a substantial improvement on the malaria situation of fifteen years ago, which is due in part to 66 the implementation of artemisinin combination therapy (2) . Recent reports of reduced efficacy in 67 Southeast Asia have raised concerns that parasites are evolving resistance (or tolerance) to 68 artemisinins and their partner drugs (3, 4) . The discovery and validation of new anti-malarial 69 targets is therefore a critical component of a robust anti-malarial pipeline, which is needed to 70 safeguard recent advances and to devise strategies for eradication. 71
Enzymes of the serine hydrolase superfamily encompass a highly diverse range of 72 catalytic activities and have garnered much attention for their roles in many critical metabolic 73 processes in humans (5, 6) . Based on annotated sequence homologies, the P. falciparum genome 74 encodes over 40 putative members of the serine hydrolase superfamily (7) , most of which have 75 not been functionally characterized. Exploration of the roles of uncharacterized serine hydrolases 76 will lead to new insights into essential aspects of parasite metabolism and possibly to new 77 chemotherapeutic targets. 78
Serine hydrolase-directed activity-based probes (ABPs) have emerged as powerful tools 79 for the functional annotation of serine hydrolases in complex proteomes (5, 8) . By enabling 80 competitive activity-based protein profiling (ABPP), ABPs have greatly accelerated the 81 discovery of inhibitors that are highly specific for individual serine hydrolases (5) . ABPs 82 containing a fluorophosphonate (FP) warhead provide broad coverage of the serine hydrolase 83 superfamily with negligible off-target activity (9, 10). Reaction of the FP warhead with the active 84 site serine forms a stable covalent adduct. ABPs containing a fluorescent reporter enable a direct 85 quantitative readout of the levels of active serine hydrolases (10). 86 We have employed a fluorescent FP probe in conjunction with well-characterized serine 87 hydrolase inhibitors to profile the serine hydrolase activities of asexual intraerythrocytic P. 88 falciparum. In the course of these studies, we made the surprising discovery that a human host 89 erythrocyte serine hydrolase, acylpeptide hydrolase (APEH, EC: 3.4.19.1; also referred to as 90 acylamino acid releasing enzyme and acylaminoacyl-peptidase) is one of the most abundant 91 serine hydrolases in the developing asexual parasite. APEH is a member of the prolyl 92 oligopeptidase (POP) family of serine peptidases (clan SC, family S9C). In mammals, APEH is 93 ubiquitously expressed (11) and it has been purified from human erythrocytes as a homotetramer 94 (12, 13) . APEH was initially identified as an exopeptidase that catalyzes the hydrolysis of N-95 terminally acylated amino acids from peptides, yielding an acylamino acid and a shortened 96 peptide with a free N-terminus (14, 15) . Acetylated and formylated peptides are good substrates 97 for APEH (16, 17) . There have also been reports of APEH endopeptidase activity against 98 oxidized proteins (18) and amyloidogenic Ab peptide (19) . 99
The physiological roles of APEH in mammalian cells are not completely understood. On 100 the basis of the exopeptidase activity of APEH noted above, it has long been hypothesized that 101 APEH participates in the maturation of proteins through the removal of acetylated N-terminal 102 residues (20). Treatment of mouse T cells with a potent and highly selective inhibitor of APEH, 103 termed AA74-1, affected the acetylation status of 25 proteins, lending support for this hypothesis 104 (21). There is some evidence that APEH influences activity of the proteasome (22, 23); however, 105 the mechanistic details of this interaction remain to be elucidated. 106
Here, we have employed the fluorescent activity-based serine hydrolase probe TAMRA-107 fluorophosphonate (TAMRA-FP), the covalent triazole urea APEH inhibitor AA74-1, and anti-108 APEH antibodies to explore the properties and physiological role of the parasite-internalized 109 enzyme. 110
111

RESULTS
112
Identification of human APEH in saponin-isolated P. falciparum 113
As a first step towards a proteome-wide functional annotation of serine hydrolase 114 activities in asexual P. falciparum, we compared the TAMRA-FP labeling profiles of crude 115 lysates of uninfected erythrocytes and of saponin-isolated parasites ( Fig. 1A ). Saponin 116 selectively permeabilizes the erythrocyte plasma membrane and the parasitophorous vacuole 117 (PV) membrane of parasite-infected red blood cells; thus, saponin-treated parasites lack soluble 118 erythrocyte and PV proteins (24). Unsurprisingly, there is little overlap between the two profiles, 119 which is consistent with an organism-specific pattern of serine hydrolase expression. 120
To gain insight into the functionality of P. falciparum serine hydrolases, competitive 121 activity-based probe profiling (referred to as competitive ABPP) was conducted. Crude lysates of 122 saponin-isolated parasites were incubated with covalent inhibitors of diverse human serine 123 hydrolases prior or vehicle (1% DMSO) prior to TAMRA-FP labeling ( Fig. 1B ; structures of 124 inhibitors and their known targets are provided in Table S1 ). We were intrigued to find that 125 AA74-1, a triazole urea inhibitor (Fig. 1C ) that is highly selective for human APEH (21), 126 completely blocked TAMRA-FP labeling of a major ~55 kDa species and a minor ~80 kDa 127 species in parasite lysate ( Fig. 1B) . In contrast, lipase or fatty acid amide hydrolase inhibitors did 128 not compete with labeling of the 55 or 80 kDa species (Fig. 1B) . Treatment of erythrocyte lysate 129 Parasite and erythrocyte lysates were first analyzed by competitive ABPP with and without 138 AA74-1 to identify APEH ( Fig. 1E ). After in-gel fluorescence scanning of TAMRA-FP-labeled 139 species, the proteins were transferred to nitrocellulose and APEH was detected by 140 immunoblotting. The 80 kDa species in erythrocyte lysate and the major 55 kDa and minor 80 141 kDa species in parasite lysate were recognized by the antibody, with the relative abundance of 142 the species on the membrane comparable to that observed in the TAMRA-FP scan ( Fig. 1E ). 143
These findings strongly suggest that P. falciparum internalizes APEH, which then appears to 144 undergo a proteolytic event to reduce the size of the active site-containing segment from 80 to 55 145 kDa. The minor ~80 kDa species in parasite lysate that is inhibited by AA74-1 likely represents 146 full-length, uncleaved APEH. Hereafter, these two species will be collectively referred to as 147 "parasite-internalized APEH". 148 149
Validation of AA74-1 as a potent and selective inhibitor of parasite-internalized APEH 150
Before using AA74-1 to probe the importance of internalized APEH for intraerythrocytic 151 parasite development, we evaluated its potency and selectivity in vitro. The 50% inhibitory 152 concentration (IC50) values for AA74-1 inhibition of erythrocyte and parasite-internalized APEH 153 were determined by competitive ABPP ( Fig. 2A, B ). Mean IC50 values from three independent 154 replicates were 7.9 ± 1.8 nM for the parasite 55 kDa species and 7.4 ± 2.4 nM for the erythrocyte 155 80 kDa species, which are not significantly different (two-tailed Student's t-test, p-value = 0.78). 156
These values are very close to the 11 nM IC50 value reported for AA74-1 inhibition of APEH in 157 a human cell line using a similar competitive ABPP assay (21). The parasite 80 kDa species 158 appeared to have a comparable IC50 value ( Fig. 2A ), but its lower abundance made it difficult to 159 reliably quantify this species. 160
To assess the selectivity of AA74-1 for APEH in saponin-isolated parasite lysate, the 161 fluorescence profiles of the lanes corresponding to 135 and 405 nM AA74-1 in Fig. 2A were 162 compared to that of the vehicle (DMSO) control ( Fig. 2C ). At both concentrations, the 80 and 55 163 kDa APEH species were effectively inhibited ( Fig. 2C , red asterisks). A 37 kDa species was 164 partially inhibited at both concentrations. In separate studies, we have identified this species as 165 the "prodrug activation and resistance esterase" (R. Elahi, C. Dapper and M. Klemba, 166 unpublished data), a serine hydrolase that is not essential for asexual replication of P. falciparum 167 (31). We conclude that concentrations of AA74-1 below ~400 nM are highly selective for the 55 168 and 80 kDa species of APEH in saponin-isolated parasite lysate in vitro. 169
170
The anti-malarial potency of AA74-1 is enhanced over two replication cycles 171
To determine whether internalized APEH is required for efficient parasite replication, we 172 examined the effect of AA74-1 on the development of a synchronized ring-stage culture. Parasite 173 replication was assessed by measuring the fluorescence of the DNA-binding dye SYBR Green I 174 after 48 h (the time required for one complete cycle of the 3D7 line is ~42 h). AA74-1 was a 175 relatively poor inhibitor of parasite growth, with incomplete inhibition of parasite replication at 176 10 µM and an estimated 50% effective concentration (EC50) greater than 1 µM ( Fig. 3A , Table  177 1). Interestingly, however, when parasites were seeded at a lower density and allowed to proceed 178 through two replication cycles (96 h), the efficacy of AA74-1 increased by over 10-fold, 179 exhibiting a mean EC50 value of 96 ± 38 nM over three biological replicates ( Fig. 3A , Table 1 ). 180
Near complete inhibition of parasite replication on the second cycle was observed at an AA74-1 181 concentration of 310 nM, a value that is highly selective for APEH in vitro (Fig. 2B ). In contrast 182 to these results, parallel experiments with chloroquine yielded 48 and 96 hour EC50 values that 183
were not significantly different (Table 1 ; Student's two-tailed t-test, p-value = 0.93). 184
Dramatic enhancement of anti-malarial potency during a second replication cycle is a 185 hallmark of compounds that target the P. falciparum apicoplast (26, 27) and is referred to as 186 "delayed death". An apicoplast-based delayed death response can be reversed by 187 supplementation of parasite culture medium with 200 µM isopentenyl pyrophosphate (IPP), 188 which is the sole product of apicoplast metabolism that is required during the asexual growth 189 cycle (26). To determine whether the enhanced potency of AA74-1 might be due to inhibition of 190 an apicoplast enzyme, we conducted 96 hour growth assays in the presence and absence of 200 191 µM IPP. As a positive control for delayed death, parallel experiments were performed with 192 clindamycin, an antibiotic that targets the apicoplast. Clindamycin has been shown to exhibit a 193 profound delayed death response, which can be rescued by IPP supplementation (26, 27). While 194 clindamycin toxicity was dramatically attenuated in the presence of IPP ( Fig. 3B, Table 1 ), the 195 potency of AA74-1 was unaffected ( Fig. 3A , Table 1 ). These results strongly suggest that AA74-196 1 does not target an apicoplast enzyme and indicate that an alternate mechanism lies behind the 197 enhancement of AA74-1 potency during the second replication cycle. 198 199
Parasite-internalized APEH, but not erythrocyte APEH, is recalcitrant to AA74-1 200 inhibition in vivo 201
Seeking an explanation for the enhanced potency of AA74-1 during the second 202 replication cycle, we asked whether AA74-1 is an effective inhibitor of parasite-internalized 203 APEH in vivo. Because AA74-1 covalently modifies the active site serine of APEH (21), the 204 inhibitor can be added to parasite cultures for a defined period of time and the extent of APEH 205 inhibition in vivo can be assessed by TAMRA-FP labeling following inhibitor washout and 206 saponin isolation of parasites. We determined the amount of residual internalized APEH activity 207 following a four-hour treatment of cultured trophozoite-stage parasites with 0.1, 1 or 10 µM 208 AA74-1. A four-hour treatment window was selected in order to minimize the potentially 209 confounding effects of toxicity at the higher AA74-1 concentrations (Fig. 3A) . Surprisingly, 210 parasite-internalized APEH was not effectively inhibited by exogenous AA74-1 concentrations 211 up to 10 µM ( Fig. 4A) . A parallel experiment with uninfected erythrocytes demonstrated robust 212 inhibition of APEH at all exogenous AA74-1 concentrations (Fig. 4A ). These results indicate 213 that the inhibitor is able to diffuse across the erythrocyte plasma membrane but is unable to 214 inhibit APEH within the parasite. 215
To further explore this phenomenon, we conducted an experiment to determine whether 216 there was something distinctive about P. falciparum-infected erythrocytes that prevented 217 accumulation of AA74-1. Trophozoite-stage parasites were treated for four hours with 100 nM 218 exogenous AA74-1, washed extensively, and purified on a magnetic column to > 90% 219 parasitemia (this material is referred to as "pRBCs"). We then fractionated the pRBCs with 220 saponin, yielding a supernatant containing host erythrocyte APEH, and a pellet containing 221 parasite-internalized APEH. A schematic of the experimental design is shown in Fig. 4B . Once 222 again, we observed inhibition of erythrocyte APEH but not parasitize-internalized APEH ( 
Parasite-internalized APEH is active and is inhibited by AA74-1 at acidic pH 226
The most likely scenario for internalization of host cell APEH is through the endocytosis 227 of large quantities of erythrocyte cytosol and delivery to the food vacuole (see Discussion). The 228 lumen of the food vacuole is acidic with a pH of ~ 5.5 (28, 29). To determine whether APEH 229 could have a catalytic role at this pH, we asked whether TAMRA-FP modifies the active site 230 serine of APEH at pH 5.5. While APEH was labeled with TAMRA-FP at pH 5.5 ( Fig. 5 ), the 231 extent of labeling was lower at pH 5.5 than at 7.4, which suggests a slower reaction rate at the 232 acidic pH value. We also found that AA74-1 is capable of inhibiting APEH at pH 5.5 in vitro 233 The most likely route for internalization of erythrocyte APEH is through the cytostomal 243 endocytic pathway that is responsible for the uptake and delivery to the food vacuole of large 244 quantities of erythrocyte cytosol (33-35). Up to 75% of erythrocyte hemoglobin, the dominant 245 constituent of erythrocyte cytosol, is internalized through this pathway (36). Because cytostomal 246 endocytosis is thought to be a non-specific process, APEH would presumably be delivered to the 247 food vacuole along with hemoglobin and other soluble erythrocyte proteins. This model for 248 APEH internalization is consistent with the observed proteolysis of parasite APEH to a 55 kDa 249 species, which may be mediated by vacuolar aspartic and cysteine endopeptidases (37). Our 250 findings are consistent with those of several previous studies demonstrating that APEH is highly 251 resistant to proteolytic degradation and that endoproteases such as trypsin, chymotrypsin and 252 elastase clip full-length, 80 kDa APEH into ~55 kDa and ~25 kDa fragments in vitro (38-41). 253
Interestingly, these studies have established that this proteolytic treatment neither disrupts the 254 homotetrameric structure of APEH nor reduces its activity (38, 39), thus providing a plausible 255 explanation for the stability of APEH in the proteolytic environment of the food vacuole. The 256 shift in size of APEH in saponin-isolated parasite lysates indicates that it does not originate from 257 contamination by host erythrocyte cytosol or from interaction with the outer leaflet of the 258 parasite plasma membrane. We have tried to confirm a food vacuole location for APEH through 259 indirect immunofluorescence using anti-APEH antibodies; however, although we have tested a 260 wide range of fixation conditions and numerous antibodies, we have not found conditions that 261 are suitable for detection of APEH in infected erythrocytes. 262
To investigate the possibility of a physiological role for internalized APEH, we employed 263 the APEH-selective inhibitor AA74-1 that was discovered in a library of triazole urea compound 264 by Cravatt and colleagues (21). The exquisite selectivity of this covalent inhibitor for APEH has 265 been demonstrated in vitro using mouse T cell lysates and in situ using cultured T cells (21). 266
Furthermore, upon treatment of mouse T cells with AA74-1, the N-terminal acetylation state of 267 ~25 endogenous proteins was altered, which indicates that AA74-1 is able to engage its target in 268 situ (21). Thus, we considered AA74-1 to be an appropriate tool for the interrogation of APEH 269 function in P. falciparum. To validate the use of AA74-1 in the context of P. falciparum-infected 270 erythrocytes, we demonstrated by competitive ABPP that the inhibitor is highly selective for 271 parasite-internalized APEH in lysates of saponin-isolated parasites at concentrations below ~400 272 nM. It is also selective for APEH in uninfected erythrocytes (Fig. S1 ). 273
When AA74-1 was added to synchronized ring-stage parasites, inhibition of growth over 274 the first replication cycle required concentrations that were much higher than those needed to 275 inhibit APEH in vitro. However, a dramatic enhancement of potency was observed if the growth 276 inhibition experiment was continued for a second replication cycle, i.e. 96 hours. Notably, the 277 EC50 for growth inhibition after the second cycle was only 12-fold higher than the IC50 observed 278 for inhibition of APEH in competitive ABPP in vitro. Furthermore, the AA74-1 concentrations 279 that yielded efficient inhibition of growth replication were within the concentration range found 280 to be highly selective by competitive ABPP (i.e., below 400 nM). Taken together, the evidence 281 strongly suggests that the growth defect observed during the second cycle is due to the selective 282 targeting of APEH. 283 Enhancement of drug potency during a second replication cycle is commonly observed 284 with inhibitors that target the parasite apicoplast (42). Our experiments with IPP 285 supplementation, however, revealed that internalized APEH is not acting in the context of the 286 apicoplast, nor is AA74-1 cross-inhibiting an apicoplast enzyme. Rather, it became clear from in 287 vivo experiments (i.e., upon addition of AA74-1 to the medium of cultured parasites) that the 288 parasite-internalized APEH species were not inhibited by AA74-1 under these conditions. This 289 outcome was not due to its inability to penetrate the host cell: the erythrocyte pool of APEH was 290 quantitatively inhibited by AA74-1, both in uninfected erythrocytes and in the erythrocyte 291 cytosol of infected cells. The reason for the recalcitrance of parasite-internalized APEH is not 292 entirely clear. If APEH resides in the food vacuole, it will experience an acidic pH; however, we 293 have demonstrated that the 55 kDa APEH species reacts with AA74-1 at pH 5.5 in vitro. It is 294 possible that AA74-1 is not able to access the lumen of the food vacuole, or that it is inactivated 295 inside the parasite by a hydrolytic enzyme. Whatever the reason, it is plausible that any parasite-296 internalized APEH that is present at the initiation of a growth inhibition experiment remains 297 active throughout the replication cycle. The enhancement of potency during the following 298 replication cycle could derive from the fact that the parasites invade erythrocytes containing 299 AA74-1-inactivated APEH and therefore internalize inactive enzyme. 300
Our findings lead us to the intriguing idea that P. falciparum has adapted to use 301 internalized APEH for a crucial metabolic function. The most apparent role for APEH, if as 302 expected it resides in the food vacuole, is in catalyzing the hydrolysis of acetylated amino acids 303 from the N-termini of peptides generated through the catabolism of endocytosed erythrocyte 304 proteins. The two most abundant cytosolic proteins in the erythrocyte are hemoglobin (composed 305 of a- and b-globin in the adult) and carbonic anhydrase-1, which are present at 97% and 1% of 306 total protein, respectively (43). While a- and b-globin have not traditionally been thought to 307 have acetylated N-termini, a proteome-wide analysis of erythrocyte proteins that explicitly 308 addressed the acetylation status of N-termini found that the dominant species of both a- and 309 b-globin are N-acetylated at a frequency of about 20% (44). Carbonic anhydrase-1 is known to 310 possess an acetylated N-terminus (45). Furthermore, proteomic studies have identified over 311 1,500 soluble erythrocyte proteins (46, 47), around 53% of which are N-terminally acetylated 312 (44). Given the large quantities of erythrocyte cytosol that are digested in the food vacuole, a 313 mechanism is likely needed for efficient removal of N-acetylated amino acids from peptides 314 generated by endoproteolytic hydrolysis, as N-blocked peptides are expected to be poor 315 substrates for the vacuolar exopeptidase dipeptidyl aminopeptidase 1 and the M1-and M24-316 family aminopeptidases PfA-M1 and PfAPP (48, 49). Although the pH optimum of human 317 erythrocyte APEH is reported to be close to neutral pH (13, 50), TAMRA-FP labeling at pH 5.5 318 strongly suggests that parasite-internalized APEH retains catalytic activity, albeit diminished, at 319 the acidic pH of the food vacuole. The co-internalization of host cell APEH could provide the 320 parasite with an elegant solution for the need to catabolize N-acetylated peptides. Our findings 321 lay the groundwork for further studies (such as metabolomic approaches) that could provide a 322 direct test of this hypothesis. Typhoon Trio flatbed scanner (GE Healthcare Life Sciences, Piscataway, NJ). Fluorescence 361 profiles and peak volumes of labeled proteins were obtained using ImageQuant TL v2005 (GE 362 Healthcare Life Sciences, Piscataway, NJ). For calculation of AA74-1 IC50 values (Fig. 2) , the 363 peak volume for the 55 kDa APEH species in saponin-isolated parasites was normalized to that 364 of a ~160 kDa species ( Fig. 2A , black asterisk) that was not inhibited by AA74-1 at any 365 concentration. Normalization of erythrocyte APEH peak volumes was conducted in a similar 366 manner (see Fig. S2 ). Table S1 . Molecular masses of markers 495 are indicated in kDa. 496 
